Streetbeat News

Stock Prices

Guggenheim analyst Robert Drbul has upgraded Ralph Lauren (NYSE:RL) from Neutral to Buy and announced a price target of $166.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 11:23 am

MSGE

Madison Square Garden Entertainment (MSGE) has filed for an offering of up to 7.15 million shares of common stock by the selling shareholders. The company also intends to purchase approximately $50 million of Class A common shares from the underwriters.

Portfolio Pulse from Charles Gross

September 18, 2023 | 11:21 am

DIS

Disney India is reportedly in talks for a potential sale, with companies including Reliance showing interest. The details of the deal are not yet disclosed.

Portfolio Pulse from Charles Gross

September 18, 2023 | 11:19 am

AAPL

ARM

PTCT

QQQ

SFIX

SPY

US stock futures are cautiously optimistic ahead of the Federal Reserve's interest rate decision due on Wednesday. The market is also watching the bond yields, oil prices, and analysts' take on the Fed decision. Stocks closed little changed in the week ended Sept. 15, reacting to various catalysts including inflation data, oil prices, Arm Holdings' IPO, Apple's iPhone launch, and a strike threat by the United Auto Worker’s union. Analyst Quincy Krosby of LPL Financial emphasized the importance of how the Fed presents its expected pause. In premarket trading, the SPDR S&P 500 ETF Trust and the Invesco QQQ ETF rose slightly.

Portfolio Pulse from Shanthi Rexaline

September 18, 2023 | 11:17 am

BCRX

RBC Capital analyst Brian Abrahams has upgraded BioCryst Pharma (NASDAQ:BCRX) from Sector Perform to Outperform and raised the price target from $9 to $10.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 11:16 am

GNSS

Genasys has revised its full-year revenue forecast downwards by 15% compared to the previous year. The company has also reduced its Q4 2023 revenue outlook to at least $10M, down from the estimated $13.22M.

Portfolio Pulse from Charles Gross

September 18, 2023 | 11:11 am

BOWL

CHPT

IOVA

MODV

Insiders at four companies, Iovance Biotherapeutics (IOVA), ModivCare (MODV), ChargePoint Holdings (CHPT), and Bowlero Corp (BOWL), have made notable purchases of their companies' stocks. IOVA director Wayne P Rothbaum acquired 5 million shares for around $26.5 million. MODV director Adam Gray bought 330,216 shares for around $10.82 million. CHPT 10% owner Bruce Chizen purchased 500,000 shares for around $2.9 million. BOWL director Alan John Young bought 4,900 shares for around $50,274.

Portfolio Pulse from Lisa Levin

September 18, 2023 | 11:10 am

ELOX

Eloxx Pharmaceuticals has reported independent confirmation of positive biopsy results in all patients treated with ELX-02 in a Phase 2 clinical study for Alport Syndrome. This news could potentially boost the company's stock in the short term.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 11:05 am

GSK

The FDA has approved GSK plc's (NYSE:GSK) Ojjaara (momelotinib) for the treatment of intermediate or high-risk myelofibrosis in adults with anemia. GSK acquired the blood cancer therapy from Sierra Oncology Inc. for $1.9 billion. This comes as a surprise after the European Medicines Agency's human medicines committee recommended not renewing the conditional marketing authorization for Blenrep, another GSK drug. GSK shares are up 1.23% in premarket trading.

Portfolio Pulse from Vandana Singh

September 18, 2023 | 10:54 am

BABA

SFTBY

Alibaba Group Holding Ltd (NYSE:BABA) is reportedly planning a $2 billion investment in Turkey, following a meeting between CEO Michael Evans and Turkey's President. The company has already invested about $1.4 billion in Turkey through its e-commerce marketplace, Trendyol. Alibaba holds a 76.1% stake in Trendyol, which reached a valuation of $16.5 billion in 2021. Other investors in Trendyol include Softbank Group Corp (OTC:SFTBY), General Atlantic, Qatar Investment Authority, and Abu Dhabi sovereign fund ADQ.

Portfolio Pulse from Shivani Kumaresan

September 18, 2023 | 10:47 am